[go: up one dir, main page]

MX366707B - Formulaciones y métodos para elaborar formulaciones para utilizarse en evacuación colónica. - Google Patents

Formulaciones y métodos para elaborar formulaciones para utilizarse en evacuación colónica.

Info

Publication number
MX366707B
MX366707B MX2015000971A MX2015000971A MX366707B MX 366707 B MX366707 B MX 366707B MX 2015000971 A MX2015000971 A MX 2015000971A MX 2015000971 A MX2015000971 A MX 2015000971A MX 366707 B MX366707 B MX 366707B
Authority
MX
Mexico
Prior art keywords
formulations
methods
granular fraction
manufacturing
intra
Prior art date
Application number
MX2015000971A
Other languages
English (en)
Other versions
MX2015000971A (es
Inventor
Fathi Reza
Laughlin Mclean Patrick
Original Assignee
Redhill Biopharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Redhill Biopharma Ltd filed Critical Redhill Biopharma Ltd
Publication of MX2015000971A publication Critical patent/MX2015000971A/es
Publication of MX366707B publication Critical patent/MX366707B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se describen en la presente formulaciones y métodos para elaborar formulaciones para uso en la evacuación colónica. En una modalidad, una formulación de dosis sólida incluye una fracción intra-granular entre-mezclada con una fracción extra-granular, en donde la fracción intra-granular incluye gránulos que comprenden al menos un agente evacuatorio osmótico, al menos un antiácido, y un primer componente excipiente farmacéuticamente aceptable, y en donde la fracción extra-granular incluye uno o más ácidos orgánicos, un elemento lubricante no metálico, y un segundo componente excipiente farmacéuticamente aceptable.
MX2015000971A 2012-07-27 2013-07-26 Formulaciones y métodos para elaborar formulaciones para utilizarse en evacuación colónica. MX366707B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261676608P 2012-07-27 2012-07-27
PCT/IB2013/001640 WO2014016671A2 (en) 2012-07-27 2013-07-26 Formulations and methods of manufacturing formulations for use in colonic evacuation

Publications (2)

Publication Number Publication Date
MX2015000971A MX2015000971A (es) 2015-07-14
MX366707B true MX366707B (es) 2019-07-22

Family

ID=49997911

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015000971A MX366707B (es) 2012-07-27 2013-07-26 Formulaciones y métodos para elaborar formulaciones para utilizarse en evacuación colónica.

Country Status (24)

Country Link
US (3) US10166219B2 (es)
EP (1) EP2877163B1 (es)
JP (1) JP6454640B2 (es)
KR (1) KR102152873B1 (es)
CN (2) CN108175773A (es)
AU (1) AU2013294737B2 (es)
BR (1) BR112015001640A2 (es)
CA (1) CA2880282C (es)
CY (1) CY1121852T1 (es)
DK (1) DK2877163T3 (es)
ES (1) ES2717282T3 (es)
HR (1) HRP20190550T1 (es)
HU (1) HUE043852T2 (es)
IL (1) IL236791B (es)
IN (1) IN2015DN00637A (es)
MX (1) MX366707B (es)
NZ (1) NZ704014A (es)
PH (1) PH12015500165A1 (es)
PL (1) PL2877163T3 (es)
PT (1) PT2877163T (es)
RU (1) RU2015106688A (es)
SI (1) SI2877163T1 (es)
TR (1) TR201904884T4 (es)
WO (1) WO2014016671A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2651415B1 (en) 2010-12-13 2020-10-07 Rite-Prep Pty Ltd. Gastric and colonic formulations and methods for making and using them
CN108175773A (zh) 2012-07-27 2018-06-19 红山生物医药有限公司 用于结肠排空的制剂和制备制剂方法
IN2013MU02911A (es) * 2013-09-10 2015-07-03 Cadila Healthcare Ltd
KR101420315B1 (ko) 2014-03-19 2014-07-17 남봉길 약학적 액제 조성물
CN109310774A (zh) 2015-08-17 2019-02-05 费林股份公司 含有匹可硫酸盐和柠檬酸镁的液体制剂
AR108992A1 (es) 2016-07-08 2018-10-17 Ferring Bv Formulaciones líquidas estabilizadas que contienen picosulfato
EP3345591A1 (en) * 2017-01-06 2018-07-11 Oystershell NV Oral dosage form for enhanced solubilization of a poorly soluble active agent and method of preparation
JP7340572B2 (ja) * 2021-08-20 2023-09-07 セトラスホールディングス株式会社 酸化マグネシウム錠剤

Family Cites Families (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459863A (en) 1966-10-14 1969-08-05 Merck & Co Inc Color-stable ascorbic acid tablet
US4186025A (en) 1975-09-25 1980-01-29 Merck & Co., Inc. Aqueous polysaccharide composition
US4452779A (en) 1982-02-03 1984-06-05 Cockerill Vernon Composition and method of treating lactating mammals
DK454683D0 (da) 1983-10-03 1983-10-03 Mogens Gjerloev Tarmreguleringsmiddel til behandling af diarre hos dyr samt anvendelse heraf
JPS62502967A (ja) 1985-04-18 1987-11-26 ザ・プロクター・アンド・ギャンブル・カンパニー 非潰瘍消化不良症の治療
US4766004A (en) 1986-12-19 1988-08-23 Warner-Lambert Company Crunchy, highly palatable, bulk-increasing, dietary fiber supplement composition
IL86859A (en) 1987-07-10 1991-12-15 E Z Em Inc Aqueous cathartic solution containing inorganic salts
JP2733849B2 (ja) 1987-10-12 1998-03-30 ボロディー，ソーマス・ユリウス 胃腸障害治療のための改良された方法
AU2900889A (en) 1987-12-24 1989-07-19 Thomas Julius Borody Orthostatic lavage solutions
CA1333564C (en) 1988-08-02 1994-12-20 Thomas Julius Borody Treatment of gastro-intestinal disorders
US5443826A (en) 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
US5213807A (en) 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin
US5232699A (en) 1990-07-26 1993-08-03 The Proctor & Gamble Company Laxative compositions
JP3425441B2 (ja) 1990-10-22 2003-07-14 ガストロ サービシイズ ピーティーワイ リミテッド 非炎症性及び非感染性腸障害の処置
US5519014A (en) 1990-10-22 1996-05-21 Borody; Thomas J. Treatment of non-inflammatory and non-infectious bowel disorders
US5173296A (en) 1990-11-16 1992-12-22 The Procter & Gamble Company Compositions containing psyllium
JPH06132767A (ja) 1992-10-22 1994-05-13 Rohm Co Ltd 圧電発振子
PT686034E (pt) 1993-02-26 2001-10-30 Procter & Gamble Forma de dosagem de bisacodil
JP2974550B2 (ja) 1993-06-01 1999-11-10 ビオフェルミン製薬株式会社 経口投与用固体組成物
AU7961094A (en) * 1993-10-19 1995-05-08 Procter & Gamble Company, The Picosulphate dosage form
JP3850891B2 (ja) 1994-03-01 2006-11-29 ゼリア新薬工業株式会社 緩下効果を有する組成物
AUPM695294A0 (en) 1994-07-20 1994-08-11 Borody, Thomas Julius Improved combination therapy dose unit
AUPM864894A0 (en) 1994-10-07 1994-11-03 Borody, Thomas Julius Treatment of bowel-dependent neurological disorders
RU2098100C1 (ru) 1995-10-11 1997-12-10 Максимова Ирина Сергеевна Ирригационный раствор для офтальмологических операций
AUPN634595A0 (en) 1995-11-03 1995-11-30 Borody, Thomas Julius Improved method for colonic evacuation
AU771576B2 (en) 1995-11-03 2004-03-25 Red Hill Biopharma Ltd. Improved preparation for colonic evacuation
NZ333493A (en) 1995-11-03 2000-06-23 Nicolas Peter Shortis Method of evacuating a patient's colon by oral administration of an osmotic colonic evacuant in powder form
US6103268A (en) 1995-11-03 2000-08-15 Borody; Thomas Julius Administering osmotic colonic evacuant containing a picosulfate
US6087386A (en) 1996-06-24 2000-07-11 Merck & Co., Inc. Composition of enalapril and losartan
DK0922464T3 (da) * 1996-07-12 2005-06-06 Daiichi Seiyaku Co Hurtigt desintegrerbare, kompressionsstöbte materialer og fremgangsmåder til fremstilling af samme
US5948787A (en) 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
US6162464A (en) 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
EP0971735B1 (en) 1997-04-01 2008-03-19 Thomas Julius Borody Methods and compositions for treating inflammatory bowel disease
US6551632B2 (en) 1997-04-01 2003-04-22 Thomas Julius Borody Methods and compositions for treating inflammatory bowel disease
WO1998047486A1 (en) 1997-04-18 1998-10-29 Taisho Pharmaceutical Co., Ltd. Microemulsion
AUPO665397A0 (en) 1997-05-07 1997-05-29 Borody, Thomas Julius Novel therapy for constipation
AR017512A1 (es) 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
CN1762335A (zh) * 1997-08-22 2006-04-26 史密丝克莱恩比彻姆公司 快速崩解的甲基纤维素片剂
AR016827A1 (es) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
JP4092748B2 (ja) 1997-09-05 2008-05-28 ニプロ株式会社 腸管洗浄液
US5843477A (en) * 1997-09-30 1998-12-01 Bayer Corporation Lubricants for use in tabletting
BR9813808A (pt) * 1997-12-19 2002-05-28 Smithkline Beecham Corp Processo para produção de comprimidos para dispersão na mordida
AUPP325398A0 (en) 1998-04-30 1998-05-21 Borody, Thomas J. Improved method for eradicating h. pylori
AUPP437698A0 (en) 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease
EP1005863A1 (en) 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
US6245740B1 (en) 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
US7763276B1 (en) 1999-02-26 2010-07-27 Shionogi & Co., Ltd. Chewable soft capsules having improved administration properties and process for producing the same
US6858403B2 (en) 1999-05-11 2005-02-22 M-Biotech, Inc. Polymer matrix containing catalase co-immobilized with analytic enzyme that generates hydrogen peroxide
DE19930030B4 (de) 1999-06-30 2004-02-19 Meduna Arzneimittel Gmbh CO-3-ungesättigte Fettsäuren enthaltende orale Darreichungsform
CN1288730A (zh) 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
US6774111B1 (en) 2000-03-14 2004-08-10 Abbott Laboratories Carbohydrate system and a method for providing nutrition to a diabetic
EP1284723A4 (en) 2000-04-19 2004-06-30 Borody Thomas J COMPILATIONS AND THERAPIES FOR HYPERLIPIDEMIA-ASSOCIATED DISEASES
EP1296693A4 (en) 2000-06-19 2005-05-25 Mucoprotec Pty Ltd IMMUNOTHERAPY AND PROBIOTIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL OR VIRAL INFECTIONS ON MUCOSAL SURFACES
AUPQ854100A0 (en) 2000-07-03 2000-07-27 Helirad Pty Ltd Methods for monitoring treatment of helicobacter infection
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
ATE303149T1 (de) 2001-02-27 2005-09-15 Ranbaxy Lab Ltd Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
US20020192345A1 (en) 2001-03-13 2002-12-19 John Kepplinger Aerated food component
US6790453B2 (en) 2001-03-14 2004-09-14 Mccormick & Company, Inc. Encapsulation compositions and process for preparing the same
US7815956B2 (en) 2001-04-27 2010-10-19 Pepsico Use of erythritol and D-tagatose in diet or reduced-calorie beverages and food products
MXPA03011017A (es) 2001-06-01 2005-04-29 Pozen Inc Composiciones farmaceuticas para la entrega coordinada de nsaids.
CN100366239C (zh) 2001-07-05 2008-02-06 涌永制药株式会社 软胶囊剂
US20030092724A1 (en) 2001-09-18 2003-05-15 Huaihung Kao Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
AUPS017702A0 (en) 2002-01-25 2002-02-14 Atopic Pty Ltd Methods and compositions for the treatment of asthma and related disorders
AUPS088702A0 (en) 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
US6753009B2 (en) 2002-03-13 2004-06-22 Mcneil-Ppc, Inc. Soft tablet containing high molecular weight polyethylene oxide
EP1492505B1 (en) 2002-04-05 2015-06-03 Euro-Celtique S.A. Pharmaceutical preparation containing oxycodone and naloxone
US6946149B2 (en) 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
JP4591742B2 (ja) 2003-01-06 2010-12-01 大正製薬株式会社 ジオクチルソジウムスルホサクシネート配合製剤およびその製造方法
AU2003900553A0 (en) 2003-02-10 2003-02-20 Borody, Thomas Julius Novel Improved Method for Detection of Dientamoeba fragilis and other Parasites
MXPA05010821A (es) 2003-04-08 2006-03-30 Progenics Pharm Inc Terapia de combinacion para constipacion que comprende un laxante y un antagonista opioide periferico.
AU2004238321B2 (en) 2003-05-07 2009-08-27 Samyang Biopharmaceuticals Corporation Highly plastic granules for making fast melting tablets
WO2005000237A2 (en) 2003-06-25 2005-01-06 University Of Tennessee Research Foundation Granules containing biologically active substances
US7687075B2 (en) 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
JP2005255595A (ja) 2004-03-10 2005-09-22 Taisho Pharmaceut Co Ltd ジオクチルソジウムスルホサクシネート配合錠剤
JP2005272401A (ja) 2004-03-25 2005-10-06 Tendou Seiyaku Kk チュアブル錠
UA86802C2 (ru) 2004-04-13 2009-05-25 Бёрингер Ингельхайм Интернациональ Гмбх Комбинация симетикона и бисакодила для предрасположенных к запору пациентов, которые страдают от ощущения вздутия живота
KR100749229B1 (ko) 2005-04-29 2007-08-13 (주)아모레퍼시픽 당 및 당알콜을 함유하는 변비개선용 조성물
US20060275223A1 (en) 2005-06-02 2006-12-07 Burr James B Erythritol compositions for teeth and gums
DE102006033014A1 (de) 2005-09-13 2007-04-05 Volkswagen Ag Eingabevorrichtung für ein Kraftfahrzeug
WO2007057924A1 (en) 2005-11-21 2007-05-24 Panacea Biotec Ltd Laxative composition on the basis of triphala
ATE489079T1 (de) 2005-12-29 2010-12-15 Osmotica Kereskedelmi Es Szolgaltata Kft Mehrschichtige tablette mit dreifacher freisetzungskombination
JP5006567B2 (ja) 2006-04-14 2012-08-22 花王株式会社 口腔用固形製剤
AU2007276874B2 (en) 2006-07-28 2010-08-19 Dr. Reddy's Laboratories Ltd. Granular pharmaceutical compositions
WO2008021394A2 (en) 2006-08-15 2008-02-21 Theraquest Biosciences, Llc Pharmaceutical formulations of cannabinoids and method of use
WO2008027442A2 (en) 2006-08-30 2008-03-06 Theraquest Biosciences, Llc Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use
ES2347197T3 (es) 2006-12-04 2010-10-26 E.I. Du Pont De Nemours And Company Composicion de revestimiento de poliol acrilico.
WO2008141368A1 (en) 2007-05-17 2008-11-27 David Lubowski Combination laxative compositions comprising a colonic stimulant and a bulking laxative
EP2155167A2 (en) 2007-06-04 2010-02-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
CA2686964A1 (en) 2007-06-06 2008-12-11 Basf Se Pharmaceutical formulation for the production of rapidly disintegrating tablets
EP2164461B1 (de) 2007-06-06 2013-01-23 Basf Se Kau- und lutsch-tabletten
CN103691530A (zh) 2007-07-27 2014-04-02 卡吉尔公司 多元醇的微粉化
EP2196221A4 (en) 2007-09-27 2011-12-28 Mitsubishi Tanabe Pharma Corp QUICKLY CRUMPING SOLID PREPARATION
BRPI0817927A2 (pt) 2007-10-01 2015-04-07 Lesvi Laboratorios Sl Comprimidos orodispersiveis
CN101406457A (zh) * 2007-10-12 2009-04-15 辉凌国际制药（瑞士）有限公司 制备药物产品的方法
CA2702152A1 (en) * 2007-10-12 2009-04-16 Haijun Xu Process for the manufacture of a pharmaceutical product
WO2009052391A1 (en) 2007-10-19 2009-04-23 Purdue Research Foundation Solid formulations of crystalline compounds
JP5258268B2 (ja) 2007-11-19 2013-08-07 フロイント産業株式会社 球形粒の製造方法
US20090155363A1 (en) 2007-12-14 2009-06-18 Todd Maibach Methods for oral administration of active drugs
US20090169622A1 (en) * 2007-12-27 2009-07-02 Roxane Laboratories, Inc. Delayed-release oral pharmaceutical composition for treatment of colonic disorders
WO2009084678A1 (ja) 2007-12-28 2009-07-09 Sawai Pharmaceutical Co., Ltd. 口腔内崩壊錠およびその製造方法
US20090258090A1 (en) 2008-04-11 2009-10-15 Braintree Laboratories, Inc. Colon cleansing solution
US20100178413A1 (en) 2008-12-17 2010-07-15 Mark Gorris Food-based Supplement Delivery System
US20100285164A1 (en) 2009-05-11 2010-11-11 Jrs Pharma Orally Disintegrating Excipient
US20120064133A1 (en) 2009-05-28 2012-03-15 Ishwar Chauhan Multiparticulate Controlled-Release Selective Serotonin Reuptake Inhibitor Formulations
JP2011019046A (ja) 2009-07-08 2011-01-27 Nec Commun Syst Ltd 通信制御装置、通信制御方法、プログラム、及び記録媒体
WO2011019045A1 (ja) * 2009-08-11 2011-02-17 富士化学工業株式会社 崩壊性粒子組成物及び口腔内速崩壊錠
EP2465540B1 (en) * 2009-08-11 2016-10-05 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and orally rapidly disintegrating tablet
JP5663238B2 (ja) 2009-08-31 2015-02-04 ライオン株式会社 内服固形製剤及びその製造方法
JP2011157348A (ja) * 2010-01-05 2011-08-18 Fuji Chem Ind Co Ltd 崩壊性高強度球状粒子組成物
JP5711520B2 (ja) 2010-01-06 2015-04-30 三洋化成工業株式会社 外用組成物
US20110218216A1 (en) 2010-01-29 2011-09-08 Kumaravel Vivek Extended release pharmaceutical composition of donepezil
JP2012079118A (ja) 2010-10-01 2012-04-19 Toyota Motor Corp 走行支援装置及び方法
EP2651415B1 (en) 2010-12-13 2020-10-07 Rite-Prep Pty Ltd. Gastric and colonic formulations and methods for making and using them
KR20140090217A (ko) 2011-10-27 2014-07-16 토마스 줄리어스 보로디 전해액 하제
CN108175773A (zh) 2012-07-27 2018-06-19 红山生物医药有限公司 用于结肠排空的制剂和制备制剂方法
US20150216806A1 (en) 2012-08-29 2015-08-06 Salix Pharmaceuticals, Inc. Laxative compositions and methods for treating constipation and related gastrointestinal diseases and conditions

Also Published As

Publication number Publication date
PT2877163T (pt) 2019-05-24
CA2880282C (en) 2020-09-01
EP2877163A2 (en) 2015-06-03
PL2877163T3 (pl) 2019-08-30
CN104797244B (zh) 2018-03-09
CA2880282A1 (en) 2014-01-30
EP2877163B1 (en) 2019-03-20
ES2717282T3 (es) 2019-06-20
WO2014016671A3 (en) 2014-03-13
PH12015500165A1 (en) 2015-03-16
US20150272937A1 (en) 2015-10-01
MX2015000971A (es) 2015-07-14
HRP20190550T1 (hr) 2019-05-31
IL236791A0 (en) 2015-03-31
IL236791B (en) 2020-08-31
US10166219B2 (en) 2019-01-01
NZ704014A (en) 2017-10-27
DK2877163T3 (en) 2019-04-15
SI2877163T1 (sl) 2019-06-28
TR201904884T4 (tr) 2019-05-21
CN104797244A (zh) 2015-07-22
WO2014016671A2 (en) 2014-01-30
US20200222375A1 (en) 2020-07-16
AU2013294737A1 (en) 2015-02-05
CY1121852T1 (el) 2020-07-31
HK1212596A1 (zh) 2016-06-17
US11058671B2 (en) 2021-07-13
US10493065B2 (en) 2019-12-03
JP6454640B2 (ja) 2019-01-16
IN2015DN00637A (es) 2015-06-26
KR102152873B1 (ko) 2020-09-08
US20190240205A1 (en) 2019-08-08
KR20150044027A (ko) 2015-04-23
CN108175773A (zh) 2018-06-19
BR112015001640A2 (pt) 2017-07-04
HUE043852T2 (hu) 2019-09-30
EP2877163A4 (en) 2015-12-09
JP2015522652A (ja) 2015-08-06
AU2013294737B2 (en) 2018-05-24
RU2015106688A (ru) 2016-09-20

Similar Documents

Publication Publication Date Title
PH12015500165A1 (en) Formulations and methods of manufacturing formulations for use in colonic evacuation
IL299897B1 (en) Devices and methods for administering multiple units of drug
WO2008146178A3 (en) A novel tablet dosage form
PH12015502755A1 (en) Insulin glargine / lixisenatide fixed ratio formulation
PH12017501084A1 (en) Insulin glargine/lixisenatide fixed ratio formulation
CL2013001942A1 (es) Composicion de suministro de farmaco biodegradable que comprende a) un copolimero de tres bloques biodegradable, b) un copolimero de dos bloques biodegradable, y c) cuando menos un principio farmaceuticamente activo; metodo para su preparacion: y su uso.
HK1218621A1 (zh) 用於治疗慢性炎症和炎性疾病的组合物及方法
CL2013000677A1 (es) Composicion farmaceutica en forma de tabletas que comprenden microgranulos gastrointestinales que contienen 100 a 800 mg de rifaximina, hasta 30% p/p de excipientes extragranulares y un recubrimiento formador de pelicula; y uso para tratar una enfermedad infecciosa y/o inflamatoria del intestino, tal como la enfermedad de crohn.
PH12016501841A1 (en) Immunosuppressant formulation
WO2011144674A3 (en) PHARMACEUTICAL FORMULATION COMPRISING INSULIN GLARGINE AND SBE4-ß-CYD
WO2014114255A3 (zh) 一种定位速释生物粘附剂及应用
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
WO2015065546A3 (en) Abuse-deterrent dosage forms
CA2863376A1 (en) Gastroretentive tablets
WO2014122460A3 (en) Pemetrexed complexes and pharmaceutical compositions containing pemetrexed complexes
WO2017079403A3 (en) Polymeric nanoparticles
HK1212917A1 (zh) 含硫酸特布他林的剂型
HK1220390A1 (zh) 包括恩曲他滨，替诺福韦，达芦那韦和利托那韦的单位剂型以及包含达芦那韦和利托那韦的单体片剂
CL2013001684A1 (es) Composicion farmaceutica de administracion oral que comprende alisporivir, un componente lipofilico, un tensoactivo y un componente hidrofilico.
IN2013MU03370A (es)
PH12018501991A1 (en) Pharmaceutical composition for use in treating fibrosis
WO2014013090A3 (en) Formulation comprising amorphous fingolimod
TN2015000156A1 (en) Dispersible tablet
NZ702849A (en) Genotype- or phenotype-based drug formulation
IN2013MU02015A (es)

Legal Events

Date Code Title Description
FG Grant or registration